Procurement of Direct‑to‑Patient Genetic Testing Service for the NHS Jewish BRCA Programme
NHS England is procuring a single lead provider to deliver direct-to-patient genetic testing for high-risk cohorts, including the NHS Jewish BRCA Testing Programme. The service will include at-home saliva testing, postal consent, written patient information, and access to a genetic counsellor hotline.
- Closed19 May 2026
- Value£3.7m
- BuyerNHS England
- CategoryHealth & medical
- RegionLondon
You'll want to look if you can deliver a direct-to-patient genetic testing pathway including at-home saliva collection, online or postal consent, written information provision, and genetic counsellor support
Possible incumbent
Institute of Cancer Research led the existing BRCA-DIRECT pathway to date. Inferred from prior awards to this buyer, not confirmed.